Schizophrenia, Drug Therapy, and Monitoring [3] (multiple letters)

New England Journal of Medicine

Volumn 350, Issue 4, 2004, Pages 415-416

  Bradford, Daniel W ^a   Stroup, T Scott ^a   De Socio, Giuseppe Vittorio Luigi ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CLOZAPINE; NEUROLEPTIC AGENT;

AGRANULOCYTOSIS; BLOOD EXAMINATION; COMORBIDITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MYOCARDITIS; PATIENT MONITORING; PRIORITY JOURNAL; SCHIZOPHRENIA; SEIZURE; CHEMICALLY INDUCED DISORDER; DRUG MONITORING; NOTE; DRUG INTERACTION;

AGRANULOCYTOSIS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DRUG MONITORING; HUMANS; SCHIZOPHRENIA; ANTI-RETROVIRAL AGENTS; DRUG INTERACTIONS; HIV INFECTIONS;

EID: 1442288064     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200401223500420     Document Type: Letter

References (0)